Melchior, Linea
Hirschmann, Astrid
Hofman, Paul
Bontoux, Christophe
Concha, Angel
Mrabet-Dahbi, Salima
Vannuffel, Pascal
Watkin, Emmanuel
Putzová, Martina
Scarpino, Stefania
Cayre, Anne
Martin, Paloma
Stoehr, Robert
Hartmann, Arndt
Funding for this research was provided by:
Copenhagen University
Article History
Received: 3 December 2023
Revised: 31 January 2024
Accepted: 5 March 2024
First Online: 16 March 2024
Change Date: 19 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00428-024-03800-0
Declarations
:
: Patients provided informed consent. The use of these patient samples was approved by the respective local Ethics Committees and was in accordance with the Declaration of Helsinki.
: Bontoux Christophe: nothing to declareCayre Anne: nothing to declareConcha Angel: nothing to declareHartmann Arndt: honoraria for lectures or consulting/advisory boards for Abbvie, Agilent, AstraZeneca, Biocartis, BMS, Boehringer Ingelheim, Cepheid, Diaceutics, Gilead, Illumina, Ipsen, Janssen, Lilly, Merck, MSD, Nanostring, Novartis, Pfizer, Qiagen, QUIP GmbH, Roche, Sanofi, 3DHistotech and other research support from AstraZeneca, Biocartis, Cepheid, Gilead, Illumina, Janssen, Nanostring, Novartis, Owkin, Qiagen, QUIP GmbH, Roche, SanofiHirschmann Astrid: nothing to declareHofman Paul: member of the Biocartis advisory boardMartin Paloma: nothing to declareMelchior Linea: nothing to declareMrabet-Dahbi Salima: nothing to declarePutzová Martina: nothing to declareScarpino Stefania: nothing to declareStoehr Robert: nothing to declareVannuffel Pascal: nothing to declareWatkin Emmanuel: honoraria for lectures or consulting/advisory boards for AstraZeneca, Janssen, MSD, Incyte, Pierre Fabre